The Montgomery judgment and pharmacist consultations

Barnett, Nina; Carr, Claudia

doi:10.1002/psb.1639

Cited by 1 publication

(2 citation statements)

References 5 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…87) would consider significant or that the doctor is or should be aware that the patient would deem is significant (Barnett & Carr, 2018;Sokol, 2015). 87).…”

Section: According To the Supreme Court Case Of Montgomery Vmentioning

confidence: 99%

“…The judgement explains that a material risk is one that a "reasonable person in the patient's position" (para. 87) would consider significant or that the doctor is or should be aware that the patient would deem is significant (Barnett & Carr, 2018;Sokol, 2015). Where people with intellectual disabilities are concerned, the Montgomery case applies to those with mental capacity only, that is, able to make decisions for themselves about treatment.…”

Section: According To the Supreme Court Case Of Montgomery Vmentioning

confidence: 99%

See 1 more Smart Citation

Do people with intellectual disabilities understand their prescription medication? A scoping review

Adams¹,

Carr

Mengoni

2019

Research Intellect Disabil

Self Cite

View full text Add to dashboard Cite

BackgroundPeople with intellectual disabilities are more likely to experience poor health than the general population and are frequently prescribed multiple medications. Therefore, it is important that people with intellectual disabilities understand their medication and potential adverse effects.MethodA scoping review explored people with intellectual disabilities' knowledge of prescription medications, their risks and how medication understanding can be improved.ResultsTen journal articles were included. People with intellectual disabilities often lacked understanding of their medication, including its name, purpose and when and how to take it. Participants were often confused or unaware of adverse effects associated with their medication. Information was sometimes explained to carers rather than people with intellectual disabilities. Some interventions and accessible information helped to improve knowledge in people with intellectual disabilities.ConclusionThere is a need for accessible and tailored information about medication to be discussed with people with intellectual disabilities in order to meet legal and best practice standards.

show abstract

“…87) would consider significant or that the doctor is or should be aware that the patient would deem is significant (Barnett & Carr, 2018;Sokol, 2015). 87).…”

Section: According To the Supreme Court Case Of Montgomery Vmentioning

confidence: 99%

Section: According To the Supreme Court Case Of Montgomery Vmentioning

confidence: 99%